Timken (TKR) Stock Forecast & Price Target

Timken is attractive because its core Engineered Bearings franchise and growing Industrial Motion platform are exposed to durable end markets such as aerospace & defense, automation, infrastructure, electrification, and industrial mobility, which together support the company’s targeted +80-150 bp of above-market sales growth over CY26-CY28 and roughly mid-single-digit growth expectations by 2028. The company’s 80/20 strategy is also improving the quality of earnings by reducing SKU complexity, pruning low-margin businesses, and exiting about $250M of net sales, with the belts divestiture alone expected to lift Industrial Motion segment adj. EBITDA margin by about +200 bp to above 21% and contribute to the broader +150-200 bp structural margin expansion target. Strong free cash flow further strengthens the outlook, as Timken generated $406M of FCF in 2025, guided to $350-$375M in CY26, and is targeting roughly $1.3B over CY26-CY28, leaving about $1.0B for capital deployment after dividends and creating room for accretive M&A, buybacks, and earnings growth while leverage remains near the midpoint of the 1.5-2.5x target range at 2.1x in 1Q26.

Timken is facing a cautious fundamental outlook because its expected organic growth remains modest at about +3% guidance midpoint for CY26, only slightly below the roughly +5% midpoint implied by its 2028 sales target after portfolio pruning, which suggests the business still depends heavily on execution rather than a clearly accelerating demand profile. Although the company is benefiting from an early-cycle recovery and secular tailwinds such as automation, reshoring, aerospace and defense, and infrastructure, those positives are partly offset by the difficulty of structurally changing organic growth and the reliance on gains from strategic verticals, cross-selling, and manufacturing improvement to deliver the majority of the anticipated upside. Its 2028 goals for $5.0-$5.2B in sales, 21-23% adjusted EBITDA margin, and roughly $8.50 of adjusted EPS imply meaningful improvement from CY25, but the need for ~$250M of portfolio pruning and a large portion of margin expansion from operational leverage highlights execution risk and limits confidence in the durability of the growth story.